Smartlab Europe

Press Releases

The Development of Combination Therapies to Treat Viral Diseases is Key to Future Treatment and the Focus of Recent Pharma Collaborations

Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the development of combination therapies for hepatitis c virus (HCV) and fixed-dose combinations and single-tablet regimens for human immunodeficiency...

Trophos announces conclusion of MitoTarget Consortium, achieving advanced understanding of neurodegenerative diseases

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the conclusion of the pan-European MitoTarget Project, the EU funded orphan disease project,...

Healthy Life Screening Announces New Venture with Akron General Medical Center

Healthy Life Screening is partnering with Akron General Medical Center to provide preventive cardiovascular and biometric screening services to corporations, patients and the Northeast Ohio community. The mission and vision of this partnership will help...

National Coalition of Pharmaceutical Distributors Expert Addresses U.S. Senate Committee on Value of Small Distributors in Health Care

An industry analyst with the National Coalition of Pharmaceutical Distributors testified today to the U.S. Senate Committee on Commerce, Science & Transportation that small distributors are an important and necessary part of the health care supply chain. Patricia Earl,...

BioFocus Expands Its Drug Discovery Offering with Proteomics Technology from Activiomics

BioFocus and Activiomics today announced a strategic alliance which will allow BioFocus to offer Activiomics’ proteomics services to its customers, to improve identification of novel targets for drug discovery and biomarkers for diagnostics. Activiomics’ proprietary technology,...

Forest Laboratories and Almirall Announce FDA Approval of Tudorza™ Pressair™ for the Long-Term Maintenance Treatment of COPD

Forest Laboratories, Inc. and Almirall, S.A. announced today that the U.S. Food and Drug Administration (FDA) has approved Tudorza™ Pressair™ for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and...

Secretary Sebelius announces innovative public-private partnerships to turn the tide together in fight against HIV/AIDS

In a speech at the opening session of the XIX International AIDS Conference (AIDS 2012), Health and Human Services (HHS) Secretary Kathleen Sebelius announced a series of innovative public-private partnerships in the fight against the HIV/AIDS epidemic. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »